PolyPid’s D-PLEX100 has been granted FDA Priority Review following acceptance [...]

Telix has dosed the first patient in a Phase 3 [...]

The European Medicines Agency (EMA) has accepted Almirall’s application to [...]

Adneuris Therapeutics has granted Zhejiang Conba Pharmaceutical exclusive rights to [...]

The European Commission has approved Erbitux (cetuximab) in combination with [...]

Merck has received FDA Breakthrough Therapy designation for enpatoran, an [...]

Abivax has reported positive topline results from Part 2 of [...]

Remepy has published new peer-reviewed findings showing that its investigational [...]

Grifols has dosed the first participant in a Phase 3 [...]

BridgeBio has published results from its pivotal Phase 3 Propel [...]